JACLYN LITTLE: Open Payments
NPI 1689085201 · CHILLICOTHE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 61 payments from 11 companies in 2025. Trend: 2023 $232 · 2024 $618 · 2025 $856
Food & beverage: $845Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $264 |
| Janssen Biotech, Inc. | 13 | $180 |
| Ardelyx, Inc. | 4 | $83 |
| Gilead Sciences, Inc. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $67 |
| Madrigal Pharmaceuticals | 3 | $56 |
| QOL Medical, LLC | 2 | $51 |
| GENZYME CORPORATION | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: TREMFYA, MAVYRET, RINVOQ, IBSRELA, REZDIFFRA, Sucraid, ENTYVIO, SKYRIZI.
Industry payments across OH — which companies pay providers there.
